title: Successful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistance.
authors.forename: André
authors.initials: A
authors.lastname: Furco
authors.forename: Bhairvi
authors.initials: B
authors.lastname: Gosrani
authors.forename: Sara
authors.initials: S
authors.lastname: Nicholas
authors.forename: Amanda
authors.initials: A
authors.lastname: Williams
authors.forename: Wunmi
authors.initials: W
authors.lastname: Braithwaite
authors.forename: Anton
authors.initials: A
authors.lastname: Pozniak
authors.forename: Graham
authors.initials: G
authors.lastname: Taylor
authors.forename: David
authors.initials: D
authors.lastname: Asboe
authors.forename: Hermione
authors.initials: H
authors.lastname: Lyall
authors.forename: Andrew
authors.initials: A
authors.lastname: Shaw
authors.forename: Moses
authors.initials: M
authors.lastname: Kapembwa
mesh_terms: D000328:Adult; D023241:Antiretroviral Therapy, Highly Active; D024921:Drug Resistance, Multiple, Viral; D005260:Female; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011272:Pregnancy, Multiple